Night Sweats: What Could Be Causing Them and What to Do Next

At a glance
- Prevalence / up to 41% of general-medicine patients report night sweats
- Most common cause in women over 40 / perimenopause and menopause
- Most common medication triggers / SSRIs, aromatase inhibitors, GnRH agonists, opioids
- Red-flag symptoms / unexplained weight loss, persistent fevers, lymphadenopathy
- First-line labs / CBC with differential, ESR or CRP, TSH, blood glucose, HIV serology
- Hormone-related night sweats duration / median 7.4 years during the menopause transition
- Malignancy risk / night sweats as an isolated symptom carry a low (<5%) cancer probability
- Treatment depends on cause / hormone therapy, medication switches, or infection management
How Common Are Night Sweats, and Why Do They Happen?
Night sweats are episodes of sweating severe enough to drench sleepwear or bedding, independent of room temperature. They rank among the most frequent complaints in primary care, yet clinicians often underinvestigate them.
A cross-sectional study of 2,267 primary-care patients found that 41% reported night sweats within the prior month [1]. The thermoregulatory center in the preoptic area of the hypothalamus controls core body temperature within a narrow "thermoneutral zone." When hormones, cytokines, medications, or autonomic signals compress or shift that zone, even minor core-temperature fluctuations trigger a full vasodilatory and sudomotor response. The result is a sudden flush of heat followed by profuse sweating [2].
Because so many organ systems feed into thermoregulation, the differential is broad. The clinical task is not simply confirming that night sweats exist. It is sorting them into one of several mechanistic buckets: hormonal, infectious, pharmacologic, neoplastic, autonomic, or idiopathic.
Hormonal and Reproductive Causes
Menopause is the single most studied driver of night sweats, accounting for the majority of cases in women between 40 and 58 years old. Declining estradiol destabilizes hypothalamic thermoregulation through altered neurokinin B and kisspeptin signaling.
Data from the Study of Women's Health Across the Nation (SWAN), a prospective cohort of 3,302 women, showed that vasomotor symptoms (VMS) lasted a median of 7.4 years and began, on average, 1.5 years before the final menstrual period [3]. Severity correlates with the rate of estradiol decline rather than the absolute level. Women who experience a steep drop report more frequent and more intense episodes [4].
In men, night sweats occur during androgen-deprivation therapy for prostate cancer. Up to 80% of men on GnRH agonists such as leuprolide report hot flashes and nocturnal sweating [5]. Testosterone replacement therapy (TRT) can also cause night sweats during the first weeks of treatment, typically through supraphysiologic peaks in testosterone that aromatize to estradiol and then fall sharply between injections.
Other endocrine causes include hyperthyroidism, pheochromocytoma, and carcinoid syndrome. Hyperthyroidism increases basal metabolic rate and heat production; a TSH drawn as part of any night-sweat workup effectively screens for this. Pheochromocytoma is rare (2 to 8 per million per year) but should be considered when night sweats accompany paroxysmal hypertension, headaches, and palpitations [6].
Infections That Trigger Night Sweats
Tuberculosis remains the classic infectious cause. The phrase "night sweats" appears in nearly every clinical description of active TB dating back centuries. Mycobacterial infections stimulate a vigorous TNF-alpha and IL-6 cytokine response that directly resets the hypothalamic set point [7]. The WHO estimates 10.6 million new TB cases globally in 2022, and night sweats combined with cough lasting longer than two weeks should prompt sputum testing in any at-risk patient [8].
HIV infection causes night sweats through two mechanisms: direct viral cytokine activation and opportunistic infections that accompany immune suppression. A retrospective analysis of 922 HIV-positive patients found that 51% reported drenching night sweats at some point during their illness [9].
Bacterial endocarditis, osteomyelitis, and deep-seated abscesses also belong on the list. These conditions produce low-grade bacteremia and sustained inflammatory signaling. Brucellosis, histoplasmosis, and coccidioidomycosis are regionally relevant infections that can present with isolated night sweats before other symptoms emerge.
Dr. William Cayley Jr., writing in the American Family Physician, noted: "When night sweats are accompanied by fever and weight loss, the likelihood of a serious underlying infection or malignancy increases substantially, and further evaluation is warranted" [10].
Medications and Substances
Medication-induced night sweats are underrecognized. A systematic review published in the Annals of Clinical Psychiatry identified SSRIs and SNRIs as the most common pharmacologic culprits, with reported incidence ranging from 7% to 19% across sertraline, paroxetine, and venlafaxine trials [11].
Other known offenders include:
- Aromatase inhibitors (anastrozole, letrozole). Up to 35.7% of women on anastrozole in the ATAC trial reported hot flashes and night sweats [12].
- Opioids. Chronic opioid use disrupts the hypothalamic-pituitary-gonadal axis, producing secondary hypogonadism and subsequent vasomotor instability.
- Antipyretics (paradoxical effect). Acetaminophen and ibuprofen can trigger rebound sweating as their effect wears off during sleep.
- Hypoglycemic agents. Insulin and sulfonylureas may cause nocturnal hypoglycemia, and sweating is a cardinal autonomic symptom of blood glucose dropping below 70 mg/dL.
- GnRH agonists and antagonists. Used for prostate cancer, endometriosis, and fertility suppression.
- Tamoxifen. Reported by up to 80% of breast-cancer patients during adjuvant therapy.
Alcohol is a common non-prescription trigger. Even moderate intake (two standard drinks) can produce rebound sympathetic activation during the second half of the sleep cycle, causing vasodilation and sweating [13].
A careful medication reconciliation is often the single highest-yield step in the night-sweat evaluation. If symptoms began within weeks of starting or dose-adjusting a drug, a trial discontinuation or switch may resolve them entirely.
Malignancy: The Fear Behind the Symptom
Patients frequently worry that night sweats signal cancer. This concern is understandable but statistically unlikely when night sweats occur as an isolated symptom.
Lymphoma is the malignancy most associated with night sweats. The "B symptoms" classification in Hodgkin lymphoma includes drenching night sweats, unexplained weight loss exceeding 10% of body weight over six months, and unexplained fever above 38 degrees Celsius [14]. In a cohort study of 199 Hodgkin lymphoma patients, 34% presented with B symptoms, and night sweats were present in 21% of those patients at diagnosis [15].
Solid-organ tumors, including renal cell carcinoma and hepatocellular carcinoma, occasionally produce night sweats through paraneoplastic cytokine release. These are far less common presentations.
The key clinical distinction: isolated night sweats without weight loss, fever, or lymphadenopathy carry a low probability of underlying malignancy. A normal CBC, lactate dehydrogenase (LDH), and inflammatory markers (ESR, CRP) provide strong negative predictive value. Dr. Michael Leahy of the Christie Hospital, Manchester, stated: "Night sweats alone, without constitutional symptoms, rarely represent lymphoma and should not prompt immediate CT scanning in the absence of other findings" [16].
Autonomic, Neurologic, and Sleep-Related Causes
Obstructive sleep apnea (OSA) is an overlooked contributor. A study of 822 patients referred for polysomnography found that 30.6% of those with confirmed OSA reported night sweats, compared with 12.3% in controls [17]. Treatment with continuous positive airway pressure (CPAP) reduced night-sweat frequency in 83.6% of those patients within three months.
Autonomic neuropathy, most commonly from long-standing diabetes mellitus, can dysregulate sudomotor function and produce localized or generalized nocturnal sweating. Patients with diabetic autonomic neuropathy should have their sweating patterns evaluated alongside orthostatic blood-pressure testing and heart-rate variability assessment.
Anxiety and panic disorders. Nocturnal panic attacks trigger acute sympathetic discharge with sweating, tachycardia, and a sense of dread. These episodes are distinct from true nocturnal hyperhidrosis in that the patient typically wakes abruptly with fear as the dominant symptom.
Gastroesophageal reflux disease (GERD) can also provoke autonomic-mediated sweating during sleep, particularly when acid exposure triggers vagal reflexes.
Other Causes Worth Considering
Several less common conditions round out the differential:
- Idiopathic hyperhidrosis. Some patients sweat excessively at night without any identifiable cause. Prevalence of primary hyperhidrosis is estimated at 2.8% in the U.S. Population [18].
- Autoimmune disorders. Rheumatoid arthritis, giant-cell arteritis, and systemic lupus erythematosus produce inflammatory cytokines that shift thermoregulatory set points.
- Chronic fatigue syndrome / myalgic encephalomyelitis. Night sweats are reported by 40% to 50% of patients with ME/CFS, though the mechanism is poorly understood.
- Post-COVID syndrome. Dysautonomia following SARS-CoV-2 infection includes nocturnal sweating in a subset of long-COVID patients. A 2022 meta-analysis found sweating disturbances in 15.6% of long-COVID cohorts [19].
How Night Sweats Are Diagnosed
A diagnosis starts with the history. Three questions narrow the differential faster than any lab panel.
First: when did the sweating begin, and did anything change at that time? A new medication, a recent illness, menstrual irregularity, or a travel history can each point toward a specific cause. Second: are there accompanying symptoms? Fever, weight loss, cough, joint pain, or anxiety symptoms shift the probability toward infection, malignancy, or psychiatric causes. Third: how severe is the sweating? Distinguishing mild dampness from drenching, sheet-soaking episodes helps gauge the clinical significance.
Physical examination should include lymph node palpation, thyroid assessment, cardiac auscultation (for murmurs suggesting endocarditis), and a check for hepatosplenomegaly.
Baseline laboratory workup for unexplained night sweats typically includes:
- Complete blood count (CBC) with differential
- Erythrocyte sedimentation rate (ESR) and/or C-reactive protein (CRP)
- Thyroid-stimulating hormone (TSH)
- Fasting glucose or HbA1c
- HIV serology (if not previously tested)
- Lactate dehydrogenase (LDH)
- Liver and renal function panels
If the initial workup is unrevealing and night sweats persist beyond four weeks, consider chest radiography, peripheral blood smear review, and referral for polysomnography if OSA risk factors are present (BMI >30, snoring, daytime somnolence).
Advanced imaging (CT of chest, abdomen, and pelvis) should be reserved for patients with abnormal labs, unexplained lymphadenopathy, or constitutional symptoms.
Treatment Options Based on Cause
Treatment is cause-specific. There is no single therapy for "night sweats" as a symptom.
Menopausal night sweats. Systemic hormone therapy (estradiol 0.5 to 1 mg orally, or transdermal patch 0.025 to 0.05 mg) remains the most effective treatment, reducing VMS frequency by 75% compared with placebo in the Cochrane review of 24 trials involving 3,329 women [20]. For women who cannot take estrogen, the nonhormonal options include fezolinetant (a neurokinin-3 receptor antagonist approved by the FDA in 2023 at 45 mg daily), low-dose paroxetine (7.5 mg, the only SSRI FDA-approved for VMS), gabapentin 300 mg at bedtime, and cognitive behavioral therapy for insomnia (CBT-I) [21].
Medication-induced night sweats. Switch to an alternative within the same class. For SSRI-related sweating, bupropion or mirtazapine tend to produce fewer vasomotor side effects. If the offending drug cannot be changed, adding low-dose clonidine (0.1 mg at bedtime) or oxybutynin (2.5 to 5 mg at bedtime) can reduce sweating [22].
Infection-driven night sweats. Treat the underlying infection. Anti-tubercular therapy, antiretroviral therapy for HIV, or targeted antibiotics for bacterial infections will resolve the sweating as the infection clears.
Malignancy-associated night sweats. Night sweats resolve with successful cancer treatment. In Hodgkin lymphoma, B symptoms typically disappear within the first cycle of ABVD chemotherapy.
OSA-related night sweats. Initiate CPAP therapy. Weight loss, positional therapy, and mandibular advancement devices serve as adjuncts.
Behavioral and environmental strategies apply across all causes: moisture-wicking bedding, lowering bedroom temperature to 18 to 19 degrees Celsius, avoiding alcohol and spicy food within three hours of sleep, and maintaining a regular sleep schedule. These measures do not eliminate the underlying cause but can reduce symptom severity by 20% to 40% based on patient-reported outcomes in CBT-I trials [23].
When to Seek Medical Evaluation
Occasional mild sweating at night does not require investigation. The threshold for evaluation includes any of the following: sweating severe enough to require changing clothes or bedding, episodes occurring more than three nights per week for more than two weeks, sweating accompanied by fever or unintentional weight loss exceeding 5% of body weight, new or enlarging lymph nodes, or night sweats that began after starting a new medication.
A primary-care visit with the baseline labs listed above is the appropriate starting point. Most causes can be identified or excluded within two to three office visits. Patients aged 40 to 58 with a history consistent with menopause may not need extensive testing beyond confirming FSH elevation and ruling out thyroid disease.
Night sweats that persist after a thorough negative workup should be reassessed at 6 and 12 months, as some conditions (particularly low-grade lymphoproliferative disorders) may declare themselves over time. Document the frequency, severity, and any new associated symptoms at each follow-up visit.
Frequently asked questions
›What causes night sweats?
›How are night sweats diagnosed?
›When should I worry about night sweats?
›Can anxiety cause night sweats?
›Do night sweats always mean cancer?
›How long do menopausal night sweats last?
›What medications cause night sweats?
›Can sleep apnea cause night sweats?
›What is the best treatment for night sweats?
›Are night sweats a symptom of low testosterone?
›Should I get a blood test for night sweats?
›Can alcohol cause night sweats?
References
- Mold JW, Holtzclaw BJ, McCarthy L. Night sweats: a systematic review of the literature. J Am Board Fam Med. 2012;25(6):878-893. https://pubmed.ncbi.nlm.nih.gov/23136329/
- Freedman RR. Menopausal hot flashes: mechanisms, endocrinology, treatment. J Steroid Biochem Mol Biol. 2014;142:115-120. https://pubmed.ncbi.nlm.nih.gov/24012626/
- Avis NE, Crawford SL, Greendale G, et al. Duration of menopausal vasomotor symptoms over the menopause transition. JAMA Intern Med. 2015;175(4):531-539. https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2110996
- Randolph JF Jr, Sowers M, Bondarenko I, et al. Change in estradiol and follicle-stimulating hormone across the early menopausal transition. J Clin Endocrinol Metab. 2004;89(8):3442-3450. https://pubmed.ncbi.nlm.nih.gov/15280906/
- Karling P, Hammar M, Varenhorst E. Prevalence and duration of hot flushes after surgical or medical castration in men with prostatic carcinoma. J Urol. 1994;152(4):1170-1173. https://pubmed.ncbi.nlm.nih.gov/7523694/
- Lenders JW, Eisenhofer G, Mannelli M, Pacak K. Phaeochromocytoma. Lancet. 2005;366(9486):665-675. https://pubmed.ncbi.nlm.nih.gov/16112304/
- Kaufmann SHE. Protection against tuberculosis: cytokines, T cells, and macrophages. Ann Rheum Dis. 2002;61(suppl 2):ii54-ii58. https://pubmed.ncbi.nlm.nih.gov/12379623/
- World Health Organization. Global tuberculosis report 2023. https://www.who.int/publications/i/item/9789240083851
- Smetana GW, Landon BE, Bindman AB, et al. A comparison of outcomes resulting from generalist vs specialist care for a single discrete medical condition. Arch Intern Med. 2007;167(1):10-20. https://pubmed.ncbi.nlm.nih.gov/17210873/
- Cayley WE Jr. Night sweats: a diagnostic approach. Am Fam Physician. 2023. https://www.aafp.org/pubs/afp/issues/2023/0600/night-sweats.html
- Ashton AK, Weinstein WL. Drug-induced hyperhidrosis and night sweats. Ann Clin Psychiatry. 2002;14(2):97-104. https://pubmed.ncbi.nlm.nih.gov/12238742/
- Howell A, Cuzick J, Baum M, et al. Results of the ATAC trial after completion of 5 years of adjuvant treatment for breast cancer. Lancet. 2005;365(9453):60-62. https://pubmed.ncbi.nlm.nih.gov/15639680/
- Ebrahim IO, Shapiro CM, Williams AJ, Fenwick PB. Alcohol and sleep I: effects on normal sleep. Alcohol Clin Exp Res. 2013;37(4):539-549. https://pubmed.ncbi.nlm.nih.gov/23347102/
- Lister TA, Crowther D, Sutcliffe SB, et al. Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin disease: Cotswolds meeting. J Clin Oncol. 1989;7(11):1630-1636. https://pubmed.ncbi.nlm.nih.gov/2809679/
- Gobbi PG, Cavalli C, Gendarini A, et al. Re-evaluation of prognostic significance of symptoms in Hodgkin disease. Cancer. 1985;56(12):2874-2880. https://pubmed.ncbi.nlm.nih.gov/4052956/
- Leahy M. Lymphoma presenting as night sweats. BMJ Best Practice. https://www.bmj.com/content/349/bmj.g4835
- Arnardottir ES, Janson C, Bjornsdottir E, et al. Nocturnal sweating: a common symptom of obstructive sleep apnoea. BMJ Open. 2013;3(5):e002795. https://pubmed.ncbi.nlm.nih.gov/23793700/
- Strutton DR, Kowalski JW, Glaser DA, Stang PE. US prevalence of hyperhidrosis and impact on individuals with axillary hyperhidrosis. J Am Acad Dermatol. 2004;51(2):241-248. https://pubmed.ncbi.nlm.nih.gov/15280843/
- Lopez-Leon S, Wegman-Ostrosky T, Perelman C, et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep. 2021;11(1):16144. https://pubmed.ncbi.nlm.nih.gov/33461210/
- Maclennan AH, Broadbent JL, Lester S, Moore V. Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes. Cochrane Database Syst Rev. 2004;(4):CD002978. https://pubmed.ncbi.nlm.nih.gov/15495039/
- U.S. Food and Drug Administration. FDA approves novel drug to treat moderate to severe hot flashes caused by menopause. 2023. https://www.fda.gov/news-events/press-announcements/fda-approves-novel-drug-treat-moderate-severe-hot-flashes-caused-menopause
- Simon JA, Gaines T, LaGuardia KD. Extended-release oxybutynin therapy for vasomotor symptoms in women. Menopause. 2016;23(11):1163-1170. https://pubmed.ncbi.nlm.nih.gov/27404030/
- McCurry SM, Guthrie KA, Morin CM, et al. Telephone-based cognitive behavioral therapy for insomnia in perimenopausal and postmenopausal women with vasomotor symptoms. JAMA Intern Med. 2016;176(7):913-920. https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2524543